The possible negative correlation between PNPLA3 and CAD seems to be influenced by the triglyceride metabolism and NAFLD severity related to PNPLA3 rs738409 mutation [114,115]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.